Form 8-K - Current report:
SEC Accession No. 0001104659-20-040376
Filing Date
2020-03-30
Accepted
2020-03-30 16:15:29
Documents
2
Period of Report
2020-03-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014197-1_8k.htm 8-K 18484
2 EXHIBIT 99.1 tm2014197d1_ex99-1.htm EX-99.1 30832
  Complete submission text file 0001104659-20-040376.txt   50475
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 20757213
SIC: 2834 Pharmaceutical Preparations